Matsuyama Shimin Hospital
Ehime Matsuyama, Japan
Hospital in Matsuyama
〒790-0067 Ehime, Matsuyama, Otemachi, 2 Chome−６−5
About Matsuyama Shimin Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Matsuyama Shimin Hospital
During the past decade, Matsuyama Shimin Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus
2015-05-12
2017-06-16
Completed
880
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis
2018-10-14
2021-07-15
Completed
242
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke
2022-12-05
2025-08-25
Recruiting
18,000
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Matsuyama Shimin Hospital"
#1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Matsuyama Shimin Hospital
According to Clinical.Site data, the most researched conditions in "Matsuyama Shimin Hospital" are
"Diabetes Mellitus, Type 2" (2 trials), "Heart Failure" (2 trials), "Atrial Fibrillation" (1 trials), "Diabetic Gastroparesis" (1 trials) and "Idiopathic Gastroparesis" (1 trials). Many other conditions were trialed in "Matsuyama Shimin Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Matsuyama Shimin Hospital
Most popular intervention types in "Matsuyama Shimin Hospital" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Matsuyama Shimin Hospital
The vast majority of trials in "Matsuyama Shimin Hospital" are
6 trials for "All" genders.
Clinical Trials Status at Matsuyama Shimin Hospital
Currently, there are NaN active trials in "Matsuyama Shimin Hospital".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Matsuyama Shimin Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Matsuyama Shimin Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".